Cleo Diagnostics

Follow

Cleo Diagnostics is bringing to market a simple blood test for the accurate and early diagnosis of ovarian cancer.

Contact Details

Level 2, 480 Collins Street , MELBOURNE VIC 3000

cleodx.com

Lists and Charts

Share price

Cleo Diagnostics
Closing price for the last 90 trading days

Powered by Morningstar ®

Company Activity

	NEW ROLE: Lucinda Nolan, Non-Executive Director	17 Jul 2024
	NEW ROLE: Richard Allman, Chief Executive Officer, Executive Director	17 Jul 2024
	NEW ROLE: Andrew Stephens, Chief Scientific Officer, Executive Director	17 Jul 2024

News Articles

Related Information

Notable People

Name	Position	Year Started
Richard Allman	Chief Executive Officer, Executive Director	2022
Andrew Stephens	Chief Scientific Officer, Executive Director	2022
Lucinda Nolan	Non-Executive Director	2023

Past People

Name	Position	Year Started	Year Ended
Thomas Jobling	Lead Medical Advisor, Non-Executive Director	2022
Adrien Wing	Non-Executive Chairman, Non-Executive Director	2022
Lucinda Nolan	Non-Executive Director	2023
Richard Allman	Chief Executive Officer, Executive Director	2022

ECM Deals

Date	Company	Transaction Type	Total Value
03/07/23	Cleo Diagnostics	Initial public offering	$12.00m	>>

X